AXON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Axon Enterprise Inc (AXON) is not a strong buy at the moment for a long-term beginner investor with $50,000-$100,000 available for investment. While the company shows strong revenue growth and positive industry positioning, the recent financial performance, declining net income, and EPS, combined with mixed analyst sentiment and no strong proprietary trading signals, suggest a cautious approach. Holding the stock or waiting for a better entry point may be more prudent.
The MACD histogram is positive at 19.9, indicating bullish momentum, but it is contracting, suggesting a potential slowdown. RSI is at 77.21, which is neutral but leaning towards overbought territory. Moving averages are converging, showing no clear trend. Key resistance is at 574.373, close to the current price, while support is at 506.44. Overall, the technical indicators suggest limited upside potential in the short term.
Hedge funds are significantly increasing their holdings, with a 1255.57% increase in buying activity last quarter.
Analysts highlight Axon's strong growth in AI software, international markets, and its leadership in public safety technology.
The stock has a 70% chance of gaining 2.35% in the next week and 10.93% in the next month.
Recent financial performance shows a significant drop in net income (-97.97% YoY) and EPS (-98.19% YoY), raising concerns about profitability.
Analysts have broadly lowered price targets, reflecting sector-wide valuation adjustments and negative sentiment.
No recent congress trading data or significant insider activity to support bullish sentiment.
In Q4 2025, revenue increased by 38.53% YoY to $796.7M, showing strong top-line growth. However, net income dropped drastically by 97.97% YoY to $2.75M, and EPS fell by 98.19% to $0.03. Gross margin also declined by 3.71% to 57.9%, indicating potential cost pressures or inefficiencies.
Analysts maintain a generally positive outlook with multiple Buy and Overweight ratings, but most have lowered their price targets recently due to sector-wide valuation adjustments. The revised targets range from $570 (UBS, Neutral) to $950 (TD Cowen, Buy). Analysts highlight Axon's strong growth potential in AI and public safety but are cautious about broader market conditions.
